Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients

BACKGROUND: It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported membe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lujun, Zhu, Dawei, Feng, Jun, Zhou, You, Wang, Qi, Feng, Huijing, Zhang, Junping, Jiang, Jingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469208/
https://www.ncbi.nlm.nih.gov/pubmed/31015801
http://dx.doi.org/10.1186/s12935-019-0813-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469208/
https://www.ncbi.nlm.nih.gov/pubmed/31015801
http://dx.doi.org/10.1186/s12935-019-0813-2

Ejemplares similares